In a nutshell Current guidelines restricting aspirin based on age alone may be flawed; researchers argue decisions should be ...

Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%. | Drug Discovery And ...

Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...

Scientists believe they have discovered how the cheap painkiller aspirin can stop cancers spreading. In animal experiments they showed the drug enhanced the ability of the immune system to fight back.

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ...

Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.

Explore the groundbreaking role of Aspirin and plant-based NSAIDs in tackling inflammation and enhancing overall health.

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...